摘要:
Esters of acyl L-carnitines of general formula (I) wherein
R is a straight or branched acyl group having 2 to 16 carbon atoms, in particular isobutyryl and isovaleryl ; n is an integer comprised between 7 and 15, particularly 10 ; and, X- is the anion of a pharmacologically acceptable acid are endowed with potent antimycotic activity particularly against yeast like fungi, such as Candida albicans, the aetiologic agent of candidiasis and against filamentous fungi, such as Aspergillus fumigatus, the aetiologic agent of aspergillosis. Orally or parenterally administrable or topically applicable pharmaceutical compositions comprise an ester of formula (I) as active ingredient.
摘要:
The use of esters of L-carnitine and alkanoyl L-carnitines as cationic lipids for the intracellular delivery of pharmacologically active compounds is described. The esters according to the invention have general formula (II) wherein the R groups are as defined in the description.
摘要:
The use of esters of L-carnitine and alkanoyl L-carnitines as cationic lipids for the intracellular delivery of pharmacologically active compounds is described. The esters according to the invention have general formula (II) wherein the R groups are as defined in the description.
摘要:
Esters of acyl L-carnitines of general formula (I)
wherein R is a straight or branched acyl group having 2 to 16 carbon atoms, in particular isobutyryl and isovaleryl ; n is an integer comprised between 7 and 15, particularly 10 ; and, X- is the anion of a pharmacologically acceptable acid are endowed with potent antibacterial activity. Pharmaceutical compositions comprising an ester of formula (I) can be utilized in human therapy and in the veterinary field.
摘要:
Esters of acyl L-carnitines of general formula (I)
wherein
R is a straight or branched acyl group having 2 to 16 carbon atoms, in particular isobutyryl and isovaleryl ; n is an integer comprised between 7 and 15, particularly 10 ; and, X- is the anion of a pharmacologically acceptable acid are endowed with potent antibacterial activity. Pharmaceutical compositions comprising an ester of formula (I) can be utilized in human therapy and in the veterinary field.
摘要:
An improved process for producing valproic acid from ethyl acetoacetate is disclosed wherein both the dialkylation of ethylacetoacetate with propyl bromide and the conversion of the dialkylester thus obtained to the corresponding salt take place in a single step, in the presence of a phase-transfer catalyst, in a hydroalcoholic environment, and the salt is converted to valproic acid at pH 1-3.